Related Concept Videos
Testing a Claim about Standard Deviation
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
Uncertainty in Measurement: Accuracy and Precision
Uncertainty: Overview
Clinically Relevant Drug Product Specifications: Methods of Establishment
Uncertainty in Measurement: Reading Instruments
Uncertainty: Confidence Intervals
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Comparison of Analytical Procedures in Method Transfer and Bridging Experiments.
Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.
Precision of the reportable value-Statistical optimization of the number of replicates.
Related Experiment Video
Updated: Dec 26, 2025

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control
Published on: August 29, 2025
The Goldilocks Challenge-Controlling Uncertainty When Setting Product Specifications.
Richard K Burdick1, Julia C O'Neill2
1Burdick Statistical Consulting LLC, 7783 Renegade Hill Drive, Colorado Springs, CO 80923; and RickBASU@aol.com.
Setting product specifications too tightly early in manufacturing can lead to supply disruptions. This study shows how to control the probability of overly tight limits during early drug development.
Area of Science:
- Pharmaceutical Manufacturing
- Process Control
- Regulatory Science
Background:
- Product specifications are crucial for ensuring medical product safety and efficacy.
- Current practices often rely on limited process experience for setting initial specifications.
- Overly tight specifications can lead to supply chain issues and increased costs.
Purpose of the Study:
- To demonstrate a method for controlling overly tight product specifications during early manufacturing.
- To address the challenge of setting appropriate limits with limited process data.
- To balance patient safety with manufacturing efficiency.
Main Methods:
- Analyzing the impact of specification limits on process variability.
- Developing strategies to manage uncertainty in early-stage manufacturing.
- Controlling the probability of excursions beyond established limits.
Main Results:
- Tightly set limits do not reduce inherent process variation.
- Unrealistically tight limits increase the likelihood of product discards and supply disruptions.
- A deliberate control strategy can mitigate risks associated with early-stage specifications.
Conclusions:
- Early product specifications require careful consideration of natural process variability.
- Controlling the probability of tight intervals is essential for efficient drug development.
- Optimized specification setting ensures product quality while minimizing manufacturing risks.

